Global Portfolio Strategy

Global Portfolio Strategy | January 12, 2021

We see an S&P 500 Index fair value target range of 3,850–3,900 at year-end 2021 with potential for upside if there’s better-than-expected progress on vaccine distribution. A strong earnings rebound may enable stocks to grow into somewhat elevated valuations. Our...

Global Portfolio Strategy | December 9, 2020

Stocks rose sharply in November after falling the prior two months, as the S&P 500 Index returned nearly 11%. Progress on COVID-19 vaccines and post-election policy clarity buoyed investor sentiment, offsetting surging COVID-19 cases in the United States and many...

Global Portfolio Strategy | November 10, 2020

Stocks fell for the second straight month in October as Election Day approached and brought policy uncertainty that historically has driven volatility. While the election dominated the headlines, rising COVID-19 cases in Europe and the United States and the stimulus...

Global Portfolio Strategy | October 9, 2020

Stocks pulled back in September as COVID-19 cases rose, causing the economic recovery to begin to lose some momentum. Policymakers in Washington, DC, struggled to reach an agreement on a stimlus package, and markets got a bit jittery as Election Day approached. The...

Global Portfolio Strategy | September 11, 2020

Stocks continued their positive momentum with strong gains in August, sending the S&P 500 Index to new record highs before volatility returned in early September. The economic recovery remained on track even as the threat of COVID-19 lingers, while massive...

Global Portfolio Strategy | July 10, 2020

Stocks continued their strong run in June, despite rising COVID-19 cases in several western and southern states. Reopening progress, better-than-expected economic data, optimism around vaccine prospects, and the likelihood of more stimulus offered support. We have...